Kendell Clement

ORCID: 0000-0003-3808-0811
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Lymphocytic Leukemia Research
  • CRISPR and Genetic Engineering
  • Cytokine Signaling Pathways and Interactions
  • Acute Lymphoblastic Leukemia research
  • Epigenetics and DNA Methylation
  • Single-cell and spatial transcriptomics
  • Pluripotent Stem Cells Research
  • Advanced Breast Cancer Therapies
  • Cancer Genomics and Diagnostics
  • Multiple Myeloma Research and Treatments
  • Genomics and Chromatin Dynamics
  • Immunodeficiency and Autoimmune Disorders
  • Protein Degradation and Inhibitors
  • RNA and protein synthesis mechanisms
  • RNA modifications and cancer
  • Chronic Myeloid Leukemia Treatments
  • Innovation and Socioeconomic Development
  • Cytomegalovirus and herpesvirus research
  • CAR-T cell therapy research
  • Cancer therapeutics and mechanisms
  • Reproductive System and Pregnancy
  • Genetic Syndromes and Imprinting
  • Virus-based gene therapy research
  • Pancreatic function and diabetes
  • RNA regulation and disease

University of Utah
2024-2025

Center for Cancer Research
2018-2024

Harvard University
2014-2024

Massachusetts General Hospital
2017-2024

Kingston University
2024

Broad Institute
2014-2023

Eli and Edythe Broad Foundation
2022

Harvard Stem Cell Institute
2015-2019

Harvard–MIT Division of Health Sciences and Technology
2014-2015

Massachusetts Institute of Technology
2014

Recent innovations in single-cell Assay for Transposase Accessible Chromatin using sequencing (scATAC-seq) enable profiling of the epigenetic landscape thousands individual cells. scATAC-seq data analysis presents unique methodological challenges. experiments sample DNA, which, due to low copy numbers (diploid humans), lead inherent sparsity (1-10% peaks detected per cell) compared transcriptomic (scRNA-seq) (10-45% expressed genes cell). Such challenges generation emphasize need informative...

10.1186/s13059-019-1854-5 article EN cc-by Genome biology 2019-11-18

Abstract Sequencing-based approaches have led to new insights about DNA methylation. While many different techniques for genome-scale mapping of methylation been employed, throughput has a key limitation most. To further facilitate the methylation, we describe protocol gel-free multiplexed reduced representation bisulfite sequencing (mRRBS) that reduces workload dramatically and enables processing 96 or more samples per week. mRRBS achieves similar CpG coverage original RRBS protocol, while...

10.1186/gb-2012-13-10-r92 article EN cc-by Genome biology 2012-10-03

In normal mammalian development cytosine methylation is essential and directed to specific regions of the genome. Despite notable advances through mapping its genome-wide distribution, studying direct contribution DNA gene genome regulation has been limited by lack tools for precise manipulation. Thus, combining targeting capability CRISPR-Cas9 system with an epigenetic modifier attracted interest in scientific community. contrast profiling cleavage a nuclease competent Cas9, tracing global...

10.1038/s41467-017-02708-5 article EN cc-by Nature Communications 2018-02-05

Abstract Inflammatory breast cancer (IBC) is a difficult-to-treat disease with poor clinical outcomes due to high risk of metastasis and resistance treatment. In cancer, CD44+CD24− cells possess stem cell-like features contribute progression, we previously described CD44+CD24−pSTAT3+ cell subpopulation that dependent on JAK2/STAT3 signaling. Here report are the most frequent type in IBC commonly pSTAT3+. Combination inhibition paclitaxel decreased xenograft growth more than either agent...

10.1158/0008-5472.can-22-0423 article EN cc-by-nc-nd Cancer Research 2022-11-21
Coming Soon ...